|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01177 SINO BIOPHARM
Nominal 
3.800 -0.040 (-1.042%) | 2022/12 - Final RMB(K¥) | %Chg (Final to Final) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | 2018/12 RMB(K¥) | ||
| Turnover | 28,780,412 | 7.144% | 26,861,356 | 23,647,224 | 24,234,030 | 20,888,584 | |
| Cost of Sales | (5,795,510) | 8.691% | (5,332,095) | (5,182,320) | (4,926,268) | (4,196,932) | |
| Gross Profit | 22,984,902 | 6.761% | 21,529,261 | 18,464,904 | 19,307,762 | 16,691,652 | |
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (152,976) | -- | 13,630,790 | (3,233) | 111,385 | 59,910 | |
| Profit / (Loss) before Taxation | 5,778,604 | -68.887% | 18,572,673 | 5,013,044 | 5,690,592 | 11,429,081 | |
| Taxation | (775,986) | -60.366% | (1,957,880) | (672,377) | (902,747) | (696,236) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (2,459,048) | 22.561% | (2,006,381) | (1,569,581) | (2,026,303) | (1,686,498) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 2,543,570 | -82.588% | 14,608,412 | 2,771,086 | 2,761,542 | 9,046,347 | |
| Net Finance Costs / (Income) | 237,617 | 62.130% | 146,560 | 129,365 | (27,759) | (9,459) | |
| Depreciation & Amortisation | 1,046,984 | 5.484% | 992,556 | 1,654,836 | 1,445,611 | 1,210,224 | |
| Directors' Emoluments | -- | -- | 176,656 | 170,783 | 116,967 | 90,041 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified | |
Market Valuation Indicators
| EPS (cts) | 13.660 | -- | 77.830 | 14.740 | 14.680 | 48.773 |
| DPS (cts) | 10.505 | -- | 6.488 | 6.141 | 4.846 | 4.846 |
| Dividend Payout Ratio (%) | 76.904% | -- | 8.336% | 41.664% | 33.009% | 9.935% |
| Cash flow per share ($) | -- | -- | 0.286 | 0.283 | 0.283 | 0.275 |
| NBV per share ($) | 1.581 | -- | 1.608 | 0.888 | 0.792 | 1.545 |
| Remarks: | Real time quote last updated: 08/06/2023 13:06 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 2,543,570 |
| %Change | -82.588% |
| EPS / (LPS) | RMB 0.137 |
| NBV Per Share (¥) | RMB 1.581 |